NouraChoudhuryMD

PubMed

• First-in-human imaging with [Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate.
  Tendler, S., Dunphy, M., Agee, M., O'Donoghue, J., Aly, R., Choudhury, N., Kesner, A., Kirov, A., Mauguen, A., Baine, M., Schoder, H., Weber, W., Rekhtman, N., Lyashch...> ;Medrxiv. 2024 Jan 11
• Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced- or-Rearranged NSCLC: A Brief Report.
  Rohit Thummalapalli, Noura J Choudhury, Fiona Ehrich, Tyler Beardslee, Danielle Brazel, Shannon S Zhang, Shelby Merchant, Monica F Chen, Glenn Heller, Suresh S Ramalin...> ;JTO Clinical and Research Reports. 2023 Aug 1
• 1 citations
  The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non-Small Cell Lung Cancer.
  Noura J Choudhury, Jessica A Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran, Hira Rizvi, Kathryn C Arbour, Karissa Whiting, Ronglai Shen, Matthew H...> ;Clinical Cancer Research. 2023 Sep 1
• 11 citations
  Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation.
  Charles M Rudin, David Balli, W Victoria Lai, Allison L Richards, Evelyn Nguyen, Jacklynn V Egger, Noura J Choudhury, Triparna Sen, Andrew Chow, John T Poirier, Willia...> ;Journal of Thoracic Oncology. 2023 Sep 1
• 25 citations
  Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers.
  Noura J Choudhury, Antonio Marra, Jane S Y Sui, Jessica Flynn, Soo-Ryum Yang, Christina J Falcon, Pier Selenica, Adam J Schoenfeld, Natasha Rekhtman, Daniel Gomez, Mic...> ;Journal of Thoracic Oncology. 2023 Apr 1
• 8 citations
  Bioinformatically Expanded Next-Generation Sequencing Analysis Optimizes Identification of Therapeutically Relevant MET Copy Number Alterations in >50,000 Tumors.
  James P Solomon, Soo-Ryum Yang, Noura J Choudhury, Ryan N Ptashkin, Nasrin Eslamdoost, Christina J Falcon, Axel Martin, Andrew Plodkowski, Clare Wilhelm, Ronglai Shen,...> ;Clinical Cancer Research. 2022 Nov 1
• 1 citations
  Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With//-Rearranged Lung Cancers.
  Harper Hubbeling, Noura Choudhury, Jessica Flynn, Zhigang Zhang, Christina Falcon, Valerie W Rusch, Bernard J Park, Etay Ziv, Narek Shaverdian, Daphna Y Gelblum, Annem...> ;JCO Precision Oncology. 2022 Oct 1
• 2 citations
  Serplulimab With Chemotherapy in Extensive-Stage SCLC.
  Noura J Choudhury, Gregory J Riely> ;JAMA. 2022 Sep 27
• 15 citations
  APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas.
  P Selenica, A Marra, N J Choudhury, A Gazzo, C J Falcon, J Patel, X Pei, Y Zhu, C K Y Ng, M Curry, G Heller, Y-K Zhang, M F Berger, M Ladanyi, C M Rudin, S Chandarlapa...> ;Annals of Oncology. 2022 Dec 1
• 1 citations
  Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer research.
  Noura J. Choudhury, Gregory J. Riely, Paul Sabbatini, Matthew D. Hellmann> ;Cancer Cell. 2021 Jul 12
• 14 citations
  Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers.
  Noura J. Choudhury, Jaime L. Schneider, Tejas Patil, Viola W. Zhu, Debra A. Goldman, Soo-Ryum Yang, Christina Falcon, Andrew Do, Yunan Nie, Andrew J. Plodkowski, Jamie...> ;JTO Clinical and Research Reports. 2021 Jul 1
• 47 citations
  Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion–Positive Lung Cancer
  Jessica J. Lin, Noura J. Choudhury, Satoshi Yoda, Viola W. Zhu, Ted William Johnson, Ramin Sakhtemani, Ibiayi Dagogo-Jack, Subba R. Digumarthy, Charlotte E. Lee, Andre...> ;Clinical Cancer Research. 2021 May 15
• 12 citations
  Pilot Study of Dacomitinib for Patients With Metastatic EGFR-Mutant Lung Cancers With Disease Progression After Initial Treatment With Osimertinib.
  Noura J. Choudhury, Alex Makhnin, Yosef Tobi, Robert M Daly, Isabel R Preeshagul, Afsheen Iqbal, Linda S Ahn, Sara A. Hayes, Glenn Heller, Mark G. Kris, Gregory J Riel...> ;JCO Precision Oncology. 2021 Apr 22
• 36 citations
  Response to Standard Therapies and Comprehensive Genomic Analysis for Patients with Lung Adenocarcinoma with EGFR Exon 20 Insertions.
  Noura J. Choudhury, Adam J. Schoenfeld, Jessica Flynn, Christina Falcon, Hira Rizvi, Charles M. Rudin, Mark G. Kris, Maria E. Arcila, Glenn Heller, Helena A. Yu, Marc ...> ;Clinical Cancer Research. 2021 Mar 8
• Genomic Characterization of a RET Inhibitor-Resistant RET Fusion-Positive Lung Cancer by CSF Cell-Free DNA Hybrid Capture-Based Sequencing.
  Noura J. Choudhury, Soo-Ryum Yang, Maria E. Arcila, Abhinita Mohanty, Adrienne Boire, Alexander Drilon> ;JCO Precision Oncology. 2020 Nov 16
• 6 citations
  Lorlatinib and Bevacizumab Activity in ALK-Rearranged Lung Cancers After Lorlatinib Progression.
  Noura J. Choudhury, Robert J. Young, Matthew Sellitti, Alexandra Miller, Alexander Drilon> ;JCO Precision Oncology. 2020 Nov 2
• 6 citations
  Training Oncologists in the Time of COVID-19.
  Noura J. Choudhury, Alexander N. Shoushtari> ;The Oncologist. 2020 Jul 1
• 13 citations
  Decade in review: a new era for RET-rearranged lung cancers
  Noura J. Choudhury, Alexander Drilon> ;Translational Lung Cancer Research. 2020 Jun 30
• 12 citations
  Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center.
  Noura Choudhury, Mansooreh Eghtesad, Sabah Kadri, John F. Cursio, Lauren L. Ritterhouse, Jeremy P. Segal, Aliya N. Husain, Jyoti D. Patel> ;Oncotarget. 2019 Oct 8
• 16 citations
  WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia.
  Hongtao Liu, Yuanyuan Zha, Noura Choudhury, Gregory Malnassy, Noreen Fulton, Margaret Green, Jae-Hyun Park, Yusuke Nakamura, Richard A. Larson, Andres M. Salazar, Olat...> ;Experimental Hematology & Oncology. 2018 Jan 11
• 55 citations
  Low T-cell Receptor Diversity, High Somatic Mutation Burden, and High Neoantigen Load as Predictors of Clinical Outcome in Muscle-invasive Bladder Cancer
  Noura Choudhury, Kazuma Kiyotani, Kai Lee Yap, Alexa Campanile, Tatjana Antic, Poh Yin Yew, Gary D. Steinberg, Jae-Hyun Park, Yusuke Nakamura, Peter H. O'Donnell> ;European Urology Focus. 2016 Oct 1
• 111 citations
  Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations
  Noura Choudhury, Alexa Campanile, Tatjana Antic, Kai Lee Yap, Carrie Fitzpatrick, James L. Wade, Theodore Karrison, Walter M. Stadler, Yusuke Nakamura, Peter H. O'Donnell> ;Journal of Clinical Oncology. 2016 Sep 27
• 20 citations
  Importance of immunopharmacogenomics in cancer treatment: Patient selection and monitoring for immune checkpoint antibodies.
  Noura Choudhury, Yusuke Nakamura> ;Cancer Science. 2016 Feb 1
• 127 citations
  β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
  Jinhua Xu, Jenifer R. Prosperi, Noura Choudhury, Olufunmilayo I. Olopade, Kathleen H. Goss> ;Plos One. 2015 Feb 6
• 23 citations
  Establishment of CYP2D6 reference samples by multiple validated genotyping platforms.
  Hua Fang, Xiao Liu, Jacqueline Ramírez, Noura Choudhury, Michiaki Kubo, Hae Kyung Im, Anuar Konkashbaev, Nancy J. Cox, Mark J. Ratain, Yusuke Nakamura, Peter H. O'Donnell> ;The Pharmacogenomics Journal. 2014 Jul 1
• Join now to see all

Lectures

• Clinical evaluation of germline polymorphisms (SNPs) associated with disease response to capecitabine in metastatic breast cancer (MBC) (TBCRC 015). 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018